Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $140 at H.C. Wainwright
-
-
-
-
-
-
-
Incyte drug combination reduces lymphoma progression risk by 25%
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $124 at TD Cowen
-
-
-
-
-
-
-
Incyte (INCY) Reiterated at Buy by Stifel on Constructive View for Povorcitinib
-
-
-
-
-
-
-
Incyte (INCY) Reiterated at Buy by Stifel After FDA Response to sBLA Submission
-
-
-
-
-
-
-
Incyte gets positive CHMP opinion for anal cancer drug Zynyz
-
418,726 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

